LBPO.MCB01 · 分子与细胞生物学 · Late-Breaking
Late-Breaking Research: Molecular/Cellular Biology and Genetics 1
-
- LB094 LB094 Epigenetic destabilization of chromatin compartments defines chromosomal weak links enriched for driver mutations in head and neck squamous cell carcinoma Ashley Ramos-López, Sebastián Rodríguez-Torres, Laura Palmieri, Yanira González-Rodríguez, Amanda García-Negrón, Guie Beeu Guerrero-Hunt, Adhi Guerrero-Thillet, Mariana Brait, David Sidransky, Rafael Guerrero-Preston
- LB095 LB095 Chromosomal weak links in cancer: A/B compartment rewiring coupled to global DNA methylation alterations in gastric tumorigenesis Ashley Ramos-López, Sebastián Rodríguez-Torres, Laura Palmieri, Yanira González-Rodríguez, Robert Gilman, Martha H. Jahuira-Arias, Jaime Cok, Juan Combe, Gloria Vargas, William Prado, Mariana Brait, David Sidransky, Rafael Guerrero-Preston
-
- LB097 LB097 HDAC inhibition sensitizes pancreatic cancer to DNA-damaging therapies via genome-wide redistribution of transcriptional machinery Gaoyang Liang, Hung V. T. Nguyen, Jonathan Zhu, Hervé Tiriac, Hadiqa Zafar, Daniel Y. Cao, Gabriela Estepa, Dylan C. Nelson, Yang Dai, Tae Gyu Oh, Christopher Liddle, Ruth T. Yu, Andrew M. Lowy, Weiwei Fan, Morgan L. Truitt, Annette R. Atkins, Jeremiah A. Johnson, Michael Downes, Ronald M. Evans
-
-
-
- LB102 LB102 Evaluating the therapeutic and diagnostic utility of clinical whole-genome sequencing in comparison with cancer gene panel testing Norio Tanaka, Osamu Gotoh, Ippei Fukada, Arisa Ueki, Takayuki Ueno, Shunji Takahashi, Seiichi Mori, Tetuso Noda
- LB103 LB103 Whole-genome sequencing of driver-negative renal cell carcinoma with African ancestry identifies MET structural variations missed by targeted panel sequencing Setor Amuzu, Sean A. Fletcher, Srinivas R. Viswanathan, Jie-Fu Chen, Jian Carrot-Zhang
- LB104 LB104 Marker-based tumor-normal haplotypes matching reveals genome-wide recombination and haplotype specific somatic structural variation discovery using GIAB de novo pancreatic tumor-normal assemblies Chunlin Xiao, Justin Wagner, Jennifer McDaniel, Francoise Thibaud-Nissen, Justin Zook
- LB105 LB105 Translational analyses from the randomized phase 3 DREAM3R trial: DuRvalumab with chEmotherapy as first line treAtment in advanced pleural Mesothelioma Valsamo (Elsa) Anagnostou, Anna K. Nowak, Chris Brown, Brett G. M. Hughes, Noushin Niknafs, Tracy Hoang, Jaime Wehr, Connull Leslie, Qiong Meng, Asimina Zoitou, Kennet J. O’Byrne, Wee L. Chin, Thomas John, Peter Illei, Sonia Yip, Nick Pavlakis, Julie Brahmer, Martin R. Stockler, Patrick M. Forde, Alistair Cook
- LB107 LB107 A novel short isoform of adhesion GPCR BAI3, originated from an alternative promoter, reverses the EMT process, and confers survival benefit in glioblastoma multiforme (GBM) Rashed Rezwan Parag, Virginea De Araujo Farias, Haifa A. Alsharif, Md Simul Bhuiya, Jesse Stillwell, Yuki Kuranaga, Maryam Ahmadian Elmi, Naoki Hama, Masakazu Kamata, Sushant Bhatnagar, Erwin G. Van Meir
-
